New ACOG Guidelines Recommend cfDNA-Based NIPT for All Pregnancies, Not Just Risky Ones by Glenn S. Demby | Aug 29, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet... This content is for Paid Members only.Login Register
Payors Gradually Increasing Coverage of Liquid Biopsies but Obstacles Remain by Glenn S. Demby | Jul 28, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Reimbursement-dtet... This content is for Paid Members only.Login Register
Despite Recommendations, Autism Patients Are Not Fragile X, Karyotype or CMA Testing by Glenn S. Demby | May 26, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet... This content is for Paid Members only.Login Register
New NCCN Recommends Biomarker Prostate Cancer Testing for Intermediate- & High-Risk Men by Glenn S. Demby | Mar 23, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies... This content is for Paid Members only.Login Register
FDA Finalizes CLIA Waiver Guidance for Approval of New In Vitro Diagnostic Devices by Glenn S. Demby | Mar 23, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet, Recent Headlines... This content is for Paid Members only.Login Register